India’s First Cervical Cancer Vaccine To Be Launched Today
Cervical cancer in India ranks as the 2nd most frequent cancer among 15-44 years old women. But Indian scientists have invented the country’s 1st Cervical Cancer Vaccine.
The first locally manufactured quadrivalent human papillomavirus vaccination (qHPV) against cervical cancer is being introduced in the nation’s capital today, marking a significant development in Indian medical science (September 1, 2022).
The Serum Institute of India (SII) received market authorization from the Drugs Controller General of India (DCGI) last month to produce a cervical cancer vaccine that was produced in the country.
Statement of National Technical Advisory Group on Immunization
The Chairperson of the Covid working group, National Technical Advisory Group on Immunization (NTAGI), Dr. NK Arora said,
“It is an exciting experience to launch a made-in-India vaccine. It is very exciting and I must say it makes us very happy that our daughters and granddaughters will now be able to get this much-awaited vaccine.”
He also said, “In fact, this is one of the last major vaccines to be introduced. In fact, this is one of the last vaccines that will be launched in the programme.”
“Now, Indian vaccines will be available and we hope that it will be launched in the National Immunization programme for 9-14-year-old girls.”
Indian Vaccine Is Very Effective To Prevent Cervical Cancer
Because this particular virus causes cervical cancer in 85% to 90% of cases and this vaccine protects against certain viruses, the Indian vaccine is really successful and prevents cervical cancer.
As a result, if it is given to daughters and small children, they will be protected against the virus and, likely, 30 years later, there will be no cancer.
Indian Vaccine To Fulfill The Shortage In Global Market
The Chairperson of National Technical Advisory Group on Immunization (NTAGI) said,
“There was a shortage in the global market. Now the Indian vaccine has come. So, we will be able to take care of our requirements within our made-in-India vaccine.”
Launch of Indian Cervical Cancer Vaccine
Jitendra Singh, the Union Minister for Science and Technology, will introduce the vaccination at IIC Delhi. The event will include SII CEO Adar Poonawalla, according to the officials.
The CERVAVAC qHPV vaccination has shown a strong antibody response against all targeted HPV types in both dose and age groups that is approximately 1,000 times greater than the baseline, according to the officials.